Team Gleason also tries to provide extraordinary experiences for ALS patients while at the same time raising awareness about ...

The ACT for ALS annually funds critical therapies, research, grants and a worldwide ecosystem to share biological data.

The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient ...

The amyotrophic lateral sclerosis (ALS) community is mourning Brooke Eby, an ALS advocate who documented her life with the disease on social media and helped build an online community for people ...

ALS is a neurological disorder that causes muscle weakness and eventual paralysis. The disease is progressive, meaning that symptoms usually worsen over time. However. the rate at which ALS symptoms ...

Amyotrophic lateral sclerosis (ALS) patients received better care if they were treated by a neurologist, a new study published in PLOS One has found. But researchers found that Black, older and ...

ARLINGTON, Va., Dec. 11, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has announced a first-of-its-kind directive requiring Medicare Advantage plans to approve coverage for ...

Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease in which motor neurons are gradually lost, ...

For almost a decade, I’ve fought for a cure for a disease I don’t even have yet. In 2018, when my mom was dying of the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), I learned ...

A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...

New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...